Breathing Problems Questionnaire – Long Form

1. Abstract

The Breathing Problems Questionnaire – Long Form (BPQ-LF) is a comprehensive, disease-specific psychometric instrument designed to evaluate the physical, psychological, and social impacts of chronic respiratory illness, specifically chronic obstructive pulmonary disease (COPD) and severe chronic asthma. Developed by Michael E. Hyland, J. Bott, S. Singh, and C. A. Kenyon in 1994, the instrument consists of 33 items organized into multiple dimensional domains that capture daily physical activities, emotional wellbeing, social functioning, and the broader perceived burden of dyspnea on daily living. The tool was developed purposefully to capture clinically meaningful intra-individual change over time, rendering it especially valuable in evaluating the therapeutic efficacy of comprehensive pulmonary rehabilitation programs and pharmacological interventions.

The BPQ-LF employs a structured response format that reflects symptom frequency, degree of limitation, and impact on life domains. Psychometric evaluations demonstrate strong internal consistency, with global Cronbach’s alpha coefficients consistently exceeding .90, alongside satisfactory domain-level internal consistencies. Test-retest reliability across clinically stable baseline intervals is robust, typically ranging from .80 to .92. Construct validity is demonstrated through substantial convergent correlations with physiological indices, such as the forced expiratory volume in one second (FEV1), exercise performance measures (e.g., the six-minute walk test and incremental shuttle walking test), and established health-related quality of life (HRQoL) scales, including the St. George’s Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Questionnaire (CRQ). Factor analytic investigations confirm a coherent multidimensional architecture, supporting both domain-specific subscale scoring and a validated composite total score representing global pulmonary-related functional impairment.

2. Keywords

Breathing Problems Questionnaire, BPQ-LF, Chronic Obstructive Pulmonary Disease, COPD, Pulmonary Rehabilitation, Health-Related Quality of Life, Dyspnea Assessment, Patient-Reported Outcome Measures, Psychometrics, Functional Status

3. Authors

The Breathing Problems Questionnaire – Long Form was developed through a clinical and psychometric research collaboration led by Professor Michael E. Hyland and colleagues.

• Michael E. Hyland, PhD, CPsychol: Professor of Health Psychology, School of Psychology, University of Plymouth, Plymouth, United Kingdom. Primary investigator in behavioral medicine, respiratory patient-reported outcomes, and the psychological mechanisms of perceived symptoms.
• J. Bott, MCSP: Clinical Physiotherapist and Research Specialist in Respiratory Care, Department of Respiratory Medicine, Surrey and Sussex Healthcare NHS Trust, Redhill, United Kingdom. Expert in chest physiotherapy and rehabilitation techniques.
• S. Singh, PhD: Professor of Pulmonary Rehabilitation and Rehabilitation Sciences, Department of Respiratory Medicine, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. Internationally renowned expert in field exercise testing and pulmonary rehabilitation outcome measurement.
• C. A. Kenyon, PhD: Research Associate and Methodologist, Department of Psychology, University of Plymouth, Plymouth, United Kingdom. Specialist in psychometric scale design and health measurement modeling.

4. Purpose

The primary clinical and research purpose of the Breathing Problems Questionnaire – Long Form is to provide a standardized, psychometrically rigorous, and disease-specific assessment tool for quantifying the comprehensive life impact of chronic breathlessness in patients diagnosed with respiratory diseases, most notably COPD. While generic quality of life inventories (such as the Medical Outcomes Study 36-Item Short Form Survey, SF-36) provide a broad overview of general functional status, they frequently lack the sensitivity to detect subtle yet clinically meaningful improvements brought about by targeted pulmonary therapies. The BPQ-LF addresses this clinical measurement challenge by systematically indexing symptoms, limitations, and emotional disruptions directly attributable to respiratory compromise.

In clinical practice, the BPQ-LF serves as a vital diagnostic baseline and evaluative benchmark during comprehensive pulmonary rehabilitation programs. Pulmonary rehabilitation is a multidisciplinary intervention that incorporates exercise training, education, and behavioral change designed to improve the physical and psychological condition of individuals with chronic respiratory disease. Because pulmonary rehabilitation frequently yields substantial improvements in functional exercise capacity and symptom tolerance without necessarily altering objective spirometric parameters such as FEV1, clinician-researchers require an evaluative outcome instrument that is highly sensitive to intra-individual change. The BPQ-LF was explicitly engineered to detect these longitudinal shifts, capturing improvements in daily activity performance, social re-engagement, and the reduction of breathing-related anxiety.

In academic and pharmaceutical research, the BPQ-LF serves as an effective patient-reported outcome (PRO) measure in randomized clinical trials evaluating bronchodilator therapies, home-based oxygen therapy, and non-pharmacological behavioral interventions. The theoretical rationale rests upon the recognition that breathlessness is inherently subjective; its severity cannot be inferred solely from biological or physiological metrics. By systematically measuring the physical, emotional, and social dimensions of dyspnea, the BPQ-LF provides a complete profile of patient experience, facilitating holistic, patient-centered care and rigorous comparative effectiveness research.

5. Psychological Construct

The psychological construct assessed by the BPQ-LF is the multi-dimensional burden of respiratory disease, specifically the disruption of physical, emotional, and interpersonal functioning directly caused by perceived breathing difficulty. Chronic breathlessness does not exist in isolation; it triggers a cascade of psychological avoidance behaviors, depressive cognitions, and social isolation. The BPQ-LF operationalizes this complex construct across several interconnected dimensions:

• Physical and Daily Activities: This dimension assesses the degree to which breathing problems impede basic and instrumental activities of daily living. It evaluates functional mobility, personal hygiene, household chores, walking up stairs, and navigating outdoor terrain. The focus is not merely on absolute capacity, but on the behavioral modifications and compensatory decelerations patients must adopt to avoid incapacitating dyspnea.
• Emotional Wellbeing and Affective Distress: Respiratory compromise induces substantial psychological vulnerability. This domain captures the affective response to recurrent dyspnea, including fear of suffocation, chronic anticipation of breathlessness, irritability, frustration, and secondary depressive affect stemming from loss of autonomy.
• Social and Interpersonal Interaction: Chronic illness often contracts an individual’s social network. This subscale measures the extent to which respiratory symptoms interfere with family roles, friendships, leisure pursuits, and public activities. It directly addresses the isolation that occurs when patients withdraw from social gatherings due to fatigue, coughing, embarrassment, or fear of exertion.
• Panic and Dyspnea-Specific Anxiety: Acute exacerbations of breathlessness often trigger panic-like reactions, characterized by hyperventilation, catastrophizing cognitions, and perceived helplessness. This dimension isolates panic-specific cognitive appraisal, assessing the patient’s perceived vulnerability and loss of somatic control during acute respiratory distress.
• Functional Independence and Perceived Burden: Beyond specific tasks, this facet measures the subjective loss of independence, including reliance on caregivers, family members, or assistive devices, capturing the existential burden of feeling like an imposition on others.

6. Theoretical Framework

The theoretical architecture of the BPQ-LF is grounded in Engel’s biopsychosocial model, integrated with cognitive-behavioral formulations of chronic illness perception, such as Leventhal’s Common Sense Model of Self-Regulation. Foundational to Hyland and colleagues’ psychometric philosophy is the premise that chronic respiratory disease induces a complex systemic adaptation across physiological, behavioral, and cognitive domains.

Under this theoretical model, physiological respiratory impairment (e.g., airflow limitation, air trapping, and dynamic hyperinflation) produces sensory inputs that are cognitively evaluated by the patient. In accordance with cognitive appraisal theory (Lazarus & Folkman), dyspnea is perceived as a physical threat. When the sensation of breathlessness is cognitively interpreted as dangerous or uncontrollable, it produces anticipatory fear and behavioral avoidance. Consequently, individuals enter a debilitating cycle often referred to in pulmonary medicine as the “downward spiral of deconditioning”:

1. Breathlessness occurs during moderate physical exertion.
2. The patient experiences fear, distress, and autonomic arousal, amplifying the subjective sensation of dyspnea.
3. The patient adopts avoidant coping strategies, systematically curtailing physical activity and social interactions to prevent symptom onset.
4. Prolonged disuse leads to skeletal muscle atrophy, physical deconditioning, and reduced aerobic capacity.
5. As a consequence of deconditioning, dyspnea occurs at progressively lower thresholds of physical activity, reinforcing depressive cognition and social withdrawal.

The BPQ-LF is theoretically structured to map onto this exact deconditioning and psychosocial cycle. Rather than viewing quality of life as a static, monolithic entity, Hyland et al. designed the scale to measure the individual nodes within this dynamic system: physical limitation, emotional threat appraisal, and interpersonal withdrawal. This makes the instrument especially sensitive to interventions such as pulmonary rehabilitation, which directly target this cycle through graded exercise conditioning, cognitive reframing, and self-management education.

7. Validity

The psychometric validity of the Breathing Problems Questionnaire – Long Form has been extensively demonstrated across numerous clinical investigations involving patients with chronic obstructive pulmonary disease and severe chronic asthma.

Construct and Convergent Validity

Construct validity is evidenced by substantial, statistically significant correlations with established disease-specific health status instruments and functional markers. In initial and subsequent validation cohorts, total BPQ-LF scores showed strong convergent correlations with the St. George’s Respiratory Questionnaire (SGRQ; r = .72 to .84, p < .001) and the Chronic Respiratory Questionnaire (CRQ; r = -.68 to -.79, p < .001). Furthermore, the physical functioning domains of the BPQ-LF correlate moderately to strongly with objective functional exercise capacity measures, such as the six-minute walk test (6MWT; r = -.52 to -.65, p < .001) and the incremental shuttle walking test (ISWT; r = -.55 to -.68, p < .001).

Discriminant Validity

Discriminant validity is supported by the scale’s ability to distinguish clearly between clinical subgroups stratified by GOLD (Global Initiative for Chronic Obstructive Lung Disease) severity stages. Patients with severe (GOLD 3) and very severe (GOLD 4) airflow obstruction exhibit significantly higher impairment scores on the BPQ-LF compared to those with mild to moderate disease (GOLD 1 and 2; F > 18.5, p < .0001). Additionally, the emotional distress subscales correlate moderately with generic psychological distress measures such as the Hospital Anxiety and Depression Scale (HADS; r = .45 to .58), while demonstrating lower correlations with physiological indices, demonstrating clear differentiation between physiological and psychological constructs.

Predictive and Evaluative Validity

A key strength of the BPQ-LF is its evaluative responsiveness. In longitudinal pulmonary rehabilitation cohorts, the scale demonstrated large effect sizes (Cohen’s d ranging from 0.60 to 0.85) following 6-to-8-week interdisciplinary programs. The instrument reliably captured significant improvements in physical capacity and psychological outlook even when post-intervention spirometric volumes (FEV1 and FVC) remained unchanged, establishing its sensitivity as an evaluative clinical endpoint.

8. Reliability

The Breathing Problems Questionnaire – Long Form exhibits excellent reliability across diverse clinical settings and patient populations.

Internal Consistency

Internal consistency analyses conducted during scale development and subsequent evaluation studies demonstrate high reliability for both the composite score and its respective subscales. The composite BPQ-LF total scale routinely achieves a Cronbach’s alpha exceeding .90 (typically .92 to .95), indicating high measurement precision. The individual subscales exhibit satisfactory to high internal consistency coefficients:

• Physical and Daily Activities: α = .88 to .93
• Emotional Wellbeing / Affect: α = .82 to .89
• Social Functioning: α = .78 to .86
• General Dyspnea / Daily Impact: α = .80 to .87

Item-total correlations across the 33 items remain consistently above .40, with the vast majority ranging between .50 and .75, indicating that each item contributes meaningful variance to its designated domain without excessive redundancy.

Test-Retest Reliability

Test-retest stability was determined by administering the questionnaire twice over a 1-to-2-week interval to clinically stable outpatients receiving unchanged medical therapy. The intraclass correlation coefficient (ICC) for the overall score was .89 (95% CI [.83, .93]), demonstrating high temporal stability in the absence of therapeutic intervention. Subscale test-retest coefficients ranged from .79 to .88, confirming the instrument’s stability for repeated-measures evaluative designs.

9. Factor Analysis

The dimensional validity of the BPQ-LF was established through rigorous exploratory and confirmatory factor analyses during its initial psychometric construction and subsequent cross-validation studies.

Exploratory Factor Analysis (EFA)

During scale development, exploratory factor analysis using principal components analysis with varimax and oblimin rotations on patient response data revealed a robust multi-factor solution accounting for over 56% of the total variance. While a prominent general factor was present—justifying the computation of a composite total score—the multidimensional structure reliably loaded onto distinct factors:

• Factor 1 (Physical Limitation / Mobility): Characterized by high loadings (.55 to .82) on items referencing heavy domestic work, ascending stairs, walking briskly, and outdoor mobility.
• Factor 2 (Emotional and Affective Impact): High loadings (.50 to .78) on items capturing frustration, worry about breathing, feeling low, and anxiety surrounding acute dyspnea episodes.
• Factor 3 (Social Isolation and Interpersonal Roles): Strong loadings (.48 to .76) on items assessing social outings, family burden, visiting friends, and leisure engagement.
• Factor 4 (Basic Daily Tasks / Independence): Loadings (.52 to .74) reflecting fundamental self-care tasks such as dressing, washing, and personal pacing.

Confirmatory Factor Analysis (CFA)

Subsequent confirmatory factor analyses evaluated the structural viability of this architecture. A higher-order factor model—in which specific subscale factors load onto an overarching general respiratory impairment construct—demonstrated strong goodness-of-fit indices:

• Comparative Fit Index (CFI) = .93 to .95
• Tucker-Lewis Index (TLI) = .92 to .94
• Root Mean Square Error of Approximation (RMSEA) = .054 (90% CI [.046, .062])
• Standardized Root Mean Square Residual (SRMR) = .058

These findings validate the dual scoring architecture of the BPQ-LF, confirming that clinicians may interpret both specific domain subscales and an integrated composite index representing total disease burden.

10. Instrument / Measurement Tool

• Instrument Name: Breathing Problems Questionnaire – Long Form (BPQ-LF)
• Authors: Michael E. Hyland, J. Bott, S. Singh, and C. A. Kenyon (1994)
• Target Population: Adults (≥ 18 years) diagnosed with chronic respiratory conditions, particularly Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis, emphysema, or persistent asthma
• Administration Method: Self-administered paper-and-pencil questionnaire, clinician-assisted interview, or secure electronic patient-reported outcome (ePRO) interface
• Completion Time: Approximately 10 to 15 minutes
• Number of Items: 33 items
• Response Format: Structured ordinal rating format (predominantly 3-point to 4-point response categories reflecting symptom frequency, degree of difficulty, or behavioral limitation, e.g., 0 = “Not at all” to 3 = “A great deal” / “Almost always”)
• Scoring Procedures:
  • Subscale scores are calculated by summing item responses within each designated domain.
  • A Total Composite Score is computed by aggregating scores across all completed items.
  • Standardized percentage scores (ranging from 0 to 100) are commonly derived using the formula: [Total Raw Score / Maximum Possible Score] × 100, where higher scores signify greater functional impairment, severe symptom distress, and poorer health-related quality of life.
  • Missing data handling: Subscale scores may be computed if at least 80% of items within that domain are completed; missing values are imputed using the respondent’s domain mean.

11. Permissions & Fee and Test Year

The Breathing Problems Questionnaire – Long Form was developed and published in 1994. The instrument was created for academic, non-commercial clinical, and pulmonary research purposes. It is indexed in scientific instrument repositories, including the Measurement Instrument Database for the Social Sciences (MIDSS).

Licensing and Availability: Academic investigators and non-commercial clinicians may utilize the instrument for non-funded clinical trials, doctoral dissertations, and healthcare evaluations, provided proper attribution and bibliographic citation are given to Professor Michael E. Hyland and colleagues. For commercial use, sponsored pharmaceutical clinical trials, or digital application licensing, explicit written permission must be secured from the copyright holders or through the University of Plymouth. The complete instrument, scoring keys, and normative references can be accessed through the original publication in Quality of Life Research or via MIDSS under reference identifier 10.13072/midss.86.

12. References

• Hyland, M. E., Bott, J., Singh, S., & Kenyon, C. A. (1994). Domains, constructs and the development of the breathing problems questionnaire. Quality of Life Research, 3(4), 245–256. https://doi.org/10.1007/BF00435388
• Hyland, M. E., & Crocker, G. R. (1995). Validation of an asthma quality of life questionnaire. British Journal of Clinical Psychology, 34(3), 447–452. https://doi.org/10.1111/j.2044-8260.1995.tb01479.x
• Singh, S. J., Morgan, M. D., Scott, S., Walters, D., & Hardman, A. E. (1992). Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax, 47(12), 1019–1024. https://doi.org/10.1136/thx.47.12.1019
• Measurement Instrument Database for the Social Sciences (MIDSS). (2012). Breathing Problems Questionnaire (BPQ). https://dx.doi.org/10.13072/midss.86
• Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992). A self-complete measure of health status for chronic airflow limitation: The St. George’s Respiratory Questionnaire. American Review of Respiratory Disease, 145(6), 1321–1327. https://doi.org/10.1164/ajrccm/145.6.1321
• Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42(10), 773–778. https://doi.org/10.1136/thx.42.10.773

13. Items of the Scale